Harish Thanusubramanian1, Meena Kumari Kamal Kishore2, Ranjan Shetty3, Mohan Babu Amberkar2. 1. Tutor, Department of Pharmacology, Kasturba Medical College, Manipal University , Manipal, Karnataka, India . 2. Associate Professor, Department of Pharmacology, Kasturba Medical College, Manipal University , Manipal, Karnataka, India . 3. Professor and Head, Department of Cardiology, Kasturba Medical College and Hospital, Manipal University , Manipal, Karnataka, India .
Abstract
INTRODUCTION: Heart failure is one of the most common heart problems seen in the Indian population. There are various drugs used to prevent further progression of the disease. In India, there are few studies in relation to treatment outcome in a tertiary care hospital. AIM: To study the treatment outcome of drug therapies used in heart failure patients with associated co-morbidities in a tertiary care hospital. MATERIALS AND METHODS: This was an observational study conducted on 250 patients with heart failure. Details collected using the proforma were demography (age, gender); medical history; medication history for heart failure patients on admission and discharge; ejection fraction; median length of stay in hospital; number of readmissions & in-hospital mortality. RESULTS: One hundred and twenty eight patients categorized into LVSD group (ejection fraction <40%) and 122 patients in PSF group (ejection fraction > 40%). Medical history of coronary artery disease (54%) was significantly higher in LVSD group (p<0.05) and anaemia (19%) was significantly higher in PSF group (p<0.05). On admission, inotropes (30%), digoxin (59%) and statins (54%) were prescribed more in LVSD patients (p<0.05) while calcium channel blockers (20%) were prescribed more in PSF group (p<0.05). At discharge, patients with LVSD were receiving ACE inhibitors (51%), beta blockers (30%), digoxin (67%) and statins (59%) (p<0.05) while calcium channel blockers (20%) was prescribed more in PSF group. The median length of stay was slightly higher in patients with PSF (7 days) as compared to LVSD (6 days). In-hospital mortality was lower in patients with PSF (6%) than patients with LVSD (20%). The percentage of readmissions within one month was slightly higher in patients with PSF (15%) compared to LVSD (14%). CONCLUSION: Length of stay in hospital was 6-7 days in heart failure patients. In hospital mortality in LVSD patients (20%) was higher compared to PSF patients (6%). A 15% heart failure patient were readmitted within 1month of discharge.
INTRODUCTION:Heart failure is one of the most common heart problems seen in the Indian population. There are various drugs used to prevent further progression of the disease. In India, there are few studies in relation to treatment outcome in a tertiary care hospital. AIM: To study the treatment outcome of drug therapies used in heart failurepatients with associated co-morbidities in a tertiary care hospital. MATERIALS AND METHODS: This was an observational study conducted on 250 patients with heart failure. Details collected using the proforma were demography (age, gender); medical history; medication history for heart failurepatients on admission and discharge; ejection fraction; median length of stay in hospital; number of readmissions & in-hospital mortality. RESULTS: One hundred and twenty eight patients categorized into LVSD group (ejection fraction <40%) and 122 patients in PSF group (ejection fraction > 40%). Medical history of coronary artery disease (54%) was significantly higher in LVSD group (p<0.05) and anaemia (19%) was significantly higher in PSF group (p<0.05). On admission, inotropes (30%), digoxin (59%) and statins (54%) were prescribed more in LVSD patients (p<0.05) while calcium channel blockers (20%) were prescribed more in PSF group (p<0.05). At discharge, patients with LVSD were receiving ACE inhibitors (51%), beta blockers (30%), digoxin (67%) and statins (59%) (p<0.05) while calcium channel blockers (20%) was prescribed more in PSF group. The median length of stay was slightly higher in patients with PSF (7 days) as compared to LVSD (6 days). In-hospital mortality was lower in patients with PSF (6%) than patients with LVSD (20%). The percentage of readmissions within one month was slightly higher in patients with PSF (15%) compared to LVSD (14%). CONCLUSION: Length of stay in hospital was 6-7 days in heart failurepatients. In hospital mortality in LVSD patients (20%) was higher compared to PSFpatients (6%). A 15% heart failurepatient were readmitted within 1month of discharge.
Authors: Benjamin A Steinberg; Xin Zhao; Paul A Heidenreich; Eric D Peterson; Deepak L Bhatt; Christopher P Cannon; Adrian F Hernandez; Gregg C Fonarow Journal: Circulation Date: 2012-05-21 Impact factor: 29.690
Authors: M R Cowie; K F Fox; D A Wood; C Metcalfe; S G Thompson; A J S Coats; P A Poole-Wilson; G C Sutton Journal: Eur Heart J Date: 2002-06 Impact factor: 29.983
Authors: Frank Peacock; Alpesh Amin; Christopher B Granger; Charles V Pollack; Phillip Levy; Richard Nowak; Kurt Kleinschmidt; Joe Varon; Allison Wyman; Joel M Gore Journal: Am J Emerg Med Date: 2010-05-01 Impact factor: 2.469
Authors: Jane S Saczynski; Alan S Go; David J Magid; David H Smith; David D McManus; Larry Allen; Jessica Ogarek; Robert J Goldberg; Jerry H Gurwitz Journal: J Am Geriatr Soc Date: 2013-01 Impact factor: 5.562
Authors: Gregg C Fonarow; Wendy Gattis Stough; William T Abraham; Nancy M Albert; Mihai Gheorghiade; Barry H Greenberg; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young Journal: J Am Coll Cardiol Date: 2007-08-06 Impact factor: 24.094
Authors: Barry H Greenberg; William T Abraham; Nancy M Albert; Karen Chiswell; Robert Clare; Wendy Gattis Stough; Mihai Gheorghiade; Christopher M O'Connor; Jie Lena Sun; Clyde W Yancy; James B Young; Gregg C Fonarow Journal: Am Heart J Date: 2007-08 Impact factor: 4.749
Authors: Padma Kaul; Shelby D Reed; Adrian F Hernandez; Jonathan G Howlett; Justin A Ezekowitz; Yanhong Li; Yinggan Zheng; Jean L Rouleau; Randall C Starling; Christopher M O'Connor; Robert M Califf; Paul W Armstrong Journal: JACC Heart Fail Date: 2013-10-23 Impact factor: 12.035